Chien Chung Chen

Director Financiero/CFO en Vita Genomics, Inc. .

Electronic Technology

Consumer Services

Health Services

Perfil

Chien Chung Chen is currently the Chief Financial Officer at Vita Genomics, Inc. Previously, he worked as an Independent Director at Kuangli Bio-Tech Holdings Co. Ltd.
Chen received his undergraduate degree from Soochow University.

Cargos activos de Chien Chung Chen

Empresas	Cargo	Inicio
Vita Genomics, Inc. Vita Genomics, Inc. Medical/Nursing ServicesHealth Services Vita Genomics, Inc. provides drug research services. It operates as a genomics-based biotechnological and biopharmaceutical company. The firm focuses on conducting pharmacogenomics research, in vitro diagnosis product development, and specialty contract research services in both genomics and pharmacogenomics fields. It offers advanced molecular diagnostic products and services, revolutionizing the drug-development process and providing pharmacogenomic solutions. The company was founded in March 2001 and is headquartered in New Taipei City, Taiwan.	Director Financiero/CFO	-

Todos los cargos activos de Chien Chung Chen

Antiguos cargos conocidos de Chien Chung Chen.

Empresas	Cargo	Fin
KUANGLI BIO-TECH HOLDINGS CO., LTD.	Director/Miembro de la Junta	-

Ver el detalle de la experiencia de Chien Chung Chen.

Formación de Chien Chung Chen.

Soochow University

Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Chien Chung Chen.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
KUANGLI BIO-TECH HOLDINGS CO., LTD.	Electronic Technology

Empresas privadas	1
Vita Genomics, Inc. Vita Genomics, Inc. Medical/Nursing ServicesHealth Services Vita Genomics, Inc. provides drug research services. It operates as a genomics-based biotechnological and biopharmaceutical company. The firm focuses on conducting pharmacogenomics research, in vitro diagnosis product development, and specialty contract research services in both genomics and pharmacogenomics fields. It offers advanced molecular diagnostic products and services, revolutionizing the drug-development process and providing pharmacogenomic solutions. The company was founded in March 2001 and is headquartered in New Taipei City, Taiwan.	Health Services